C9 Polyclonal Antibody

C9 encodes the final component of the complement system. It participates in the formation of the Membrane Attack Complex (MAC). The MAC assembles on bacterial membranes to form a pore, permitting disruption of bacterial membrane organization. Mutations in C9 cause component C9 deficiency.

The C9 Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of the C9 protein. This antibody is produced using advanced techniques and rigorous quality control measures to ensure optimal performance and reproducibility.

The C9 Polyclonal Antibody exhibits exceptional sensitivity and specificity, making it an ideal choice for various applications, including immunohistochemistry, western blotting, and enzyme-linked immunosorbent assays (ELISA). It recognizes the C9 protein with high affinity, enabling accurate and precise quantification of C9 levels in biological samples.

This antibody is manufactured using state-of-the-art technology and undergoes stringent purification processes to eliminate any potential contaminants, ensuring maximum purity and reliability. It has been extensively validated and tested in various experimental conditions to guarantee consistent and reproducible results.

The C9 Polyclonal Antibody is supplied in a convenient and ready-to-use format, allowing for easy integration into laboratory workflows. It is provided in a liquid formulation, eliminating the need for reconstitution and minimizing the risk of sample contamination.

With its exceptional performance characteristics and reliable results, the C9 Polyclonal Antibody is an indispensable tool for researchers and scientists working in the fields of immunology, cell biology, and biomedical research. It offers a valuable resource for studying the role of C9 protein in various physiological and pathological processes, ultimately contributing to advancements in scientific knowledge and potential therapeutic interventions.